Key facts
- Smarter Diagnostics’s last known valuation is $5.0M (Oct 2023).
- It has raised $2.1M; the latest was Seed Round ($2.0M) in Jan 2026.
- Notable investors include Aligo Venture Capital, Sunfish Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Smarter Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Smarter Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Smarter Diagnostics
Provider of an AI copilot platform intended to improve athletic performance, manage injury risk and provide personalised recommendations. The company's platform offers integration of wearable data, biomechanics data, bloodwork records, medical imaging data and training and game load data, enabling sports organizations, performance centers and sports healthcare professionals to analyse performance health data and support athlete monitoring and training decisions.
- Sector
- Healthcare
- HQ
- Olsztyn, Poland
- Founded
- 2020
- Employees
- 23
- Website
- smarterdiagnostics.com/
- Ownership
- Privately Held (backing)
Smarter Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Smarter Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Smarter Diagnostics in its N-PORT filings yet. We sweep new filings monthly.